BEGIN:VCALENDAR VERSION:2.0 PRODID:-//The BioCalendar - ECPv6.17.2//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://thebiocalendar.com X-WR-CALDESC:Events for The BioCalendar REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/Los_Angeles BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20250309T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20251102T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20260308T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20261101T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20270314T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20271107T090000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20260308T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20261101T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20270314T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20271107T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;VALUE=DATE:20260818 DTEND;VALUE=DATE:20260828 DTSTAMP:20260725T054714Z CREATED:20260724T211527Z LAST-MODIFIED:20260725T054714Z UID:10856-1787011200-1787875199@thebiocalendar.com SUMMARY:The Matrix One West Coast MedTech Forum DESCRIPTION:The Matrix One West Coast MedTech Forum is a free series of expert roundtables\, educational sessions and networking events taking place across California from 18 to 27 August 2026. Designed for professionals throughout the MedTech and life sciences community\, the programme brings together regulatory affairs\, quality\, engineering\, product\, digital health and business leaders. \nAttendees will explore some of the most important issues shaping medical device development\, including practical applications of AI\, regulatory submissions\, design control\, audit readiness\, quality management\, cloud connectivity\, cybersecurity and compliant product development. Events will take place across San Francisco\, Palo Alto\, Redwood City\, Los Angeles\, Irvine and San Diego\, featuring insights from industry experts\, legal specialists\, former FDA professionals and local MedTech leaders\, alongside valuable opportunities to connect with peers. URL:https://thebiocalendar.com/event/the-matrix-one-west-coast-medtech-forum/ LOCATION:California (multiple locations)\, CA\, United States CATEGORIES:Forum END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260818T110000 DTEND;TZID=America/Los_Angeles:20260818T120000 DTSTAMP:20260714T195850Z CREATED:20260714T125327Z LAST-MODIFIED:20260714T195850Z UID:10775-1787050800-1787054400@thebiocalendar.com SUMMARY:The Future of Cell Culture Media Development: Predictive Modeling and AI DESCRIPTION:As biologics developers work to improve productivity\, reduce development timelines\, and manage manufacturing costs\, traditional media optimization approaches can become increasingly resource intensive. Predictive modeling is emerging as a complementary approach that can help integrate biological knowledge\, process data\, and artificial intelligence (AI) to support more efficient media development. \nIn this webinar\, Thermo Fisher Scientific specialists discuss how predictive modeling and AI are being applied to cell culture media development. Learn how computational modeling can help identify promising formulation strategies\, focus experimental efforts\, and support more informed development decisions while maintaining the critical role of scientific expertise. \nIn this session\, you will learn about:\n~ The emerging role of predictive modeling in cell culture media development\n~ How AI can help support formulation optimization\n~ The value of integrating biological\, analytical\, and process data\n~ How predictive modeling and scientific expertise can work together to inform development decisions \nKey topics include:\n~ Challenges with traditional media optimization approaches\n~ AI-guided formulation design and in silico modeling\n~ Human expertise in predictive model development and validation\n~ Cross-functional collaboration in AI-enabled media development\n~ Predictive modeling in biologics development \nDiscover how predictive modeling and AI are helping shape the future of cell culture media development by supporting more informed\, data-driven approaches to media optimization. URL:https://thebiocalendar.com/event/the-future-of-cell-culture-media-development-predictive-modeling-and-ai/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-18-26-Thermo-Reg-1920x250-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260818T110000 DTEND;TZID=America/Los_Angeles:20260818T120000 DTSTAMP:20260725T055842Z CREATED:20260721T180321Z LAST-MODIFIED:20260725T055842Z UID:10811-1787050800-1787054400@thebiocalendar.com SUMMARY:Outsourced Pharma Capabilities Update August 2026: Nanoparticles DESCRIPTION:Nanoparticle programs can stall when early formulation choices fail to hold up through scale-up\, tech transfer\, and manufacturing. \nJoin leading CDMO experts on August 18 at 11:00 AM ET to learn how decisions around lipid or polymer selection\, particle engineering\, process design\, and manufacturability can impact downstream success. \nRegister now to gain practical insights that will help you evaluate CDMO approaches\, ask sharper formulation questions\, and reduce risk before nanoparticle challenges become costly development setbacks. URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-august-2026-nanoparticles/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/Biocal-25.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260818T130000 DTEND;TZID=America/Los_Angeles:20260818T140000 DTSTAMP:20260725T055605Z CREATED:20260721T180509Z LAST-MODIFIED:20260725T055605Z UID:10816-1787058000-1787061600@thebiocalendar.com SUMMARY:Outsourced Pharma Capabilities Update August 2026: Oral Solid Dose Formulation DESCRIPTION:Oral solid dose programs can run into costly scale-up challenges when early formulation and process decisions aren’t built for long-term manufacturability. \nJoin leading CDMO experts on August 18 at 1:00 PM ET to explore how excipient selection\, granulation strategy\, particle engineering\, and process design can impact tech transfer\, validation\, and commercial manufacturing. \nRegister now to gain practical insights for evaluating CDMO capabilities\, identifying scale-up risks earlier\, and making more informed partner selection decisions. URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-august-2026-oral-solid-dose-formulation/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/Biocal-26.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260819T110000 DTEND;TZID=America/Los_Angeles:20260819T120000 DTSTAMP:20260812T085350Z CREATED:20260803T190658Z LAST-MODIFIED:20260812T085350Z UID:10919-1787137200-1787140800@thebiocalendar.com SUMMARY:Take the Turbulence Out of Your Transfections: Reduce AAV Titer Variability by Optimizing Delivery DESCRIPTION:In this webinar we expand on some of the processes most vulnerable to introducing titer variability\, as well as strategies to overcome sources of variability when they are unavoidable to maintain high-titer production. URL:https://thebiocalendar.com/event/take-the-turbulence-out-of-your-transfections-reduce-aav-titer-variability-by-optimizing-delivery/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/08-19-26-Mirus-Bio-Reg-1920x250-rev.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260820T110000 DTEND;TZID=America/Los_Angeles:20260820T120000 DTSTAMP:20260725T055053Z CREATED:20260717T115757Z LAST-MODIFIED:20260725T055053Z UID:10796-1787223600-1787227200@thebiocalendar.com SUMMARY:FDA Engagement Strategies And Best Practices Amid Agency Changes DESCRIPTION:How can life sciences companies developing new medicines engage the FDA successfully during a period of rapid changes in agency personnel and policies? \nShould companies adjust their agency communication strategies or ask new questions during meetings? Our deeply experienced panelists will discuss key changes at the FDA\, how companies can get the most out of agency interactions\, and strategies to lower risks and avoid regulatory surprises. \nRegister for free today and secure your spot for this important virtual event. URL:https://thebiocalendar.com/event/fda-engagement-strategies-and-best-practices-amid-agency-changes/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/26_08-LSL-HTML-600x300-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260820T110000 DTEND;TZID=America/Los_Angeles:20260820T120000 DTSTAMP:20260725T055023Z CREATED:20260724T110739Z LAST-MODIFIED:20260725T055023Z UID:10851-1787223600-1787227200@thebiocalendar.com SUMMARY:CAR-T for Relapsed/Refractory AML: From Discovery to First-in-Human Active Phase 1 Evaluation DESCRIPTION:Join Dr. Marco Davila to explore a novel anti-CD83 CAR-T design for relapsed/refractory AML that overcomes myelosuppression barriers. Register for the live session. \nDeveloping effective Chimeric Antigen Receptor (CAR) T-cell therapies for Acute Myeloid Leukemia (AML) remains one of the most formidable frontiers in cellular immunotherapy. Unlike lymphoid malignancies where lineage-specific targets like CD19 or BCMA offer a clear therapeutic window\, AML presents a severe biological bottleneck. The vast majority of well-characterized myeloid antigens (such as CD33 or CD123) are shared with healthy hematopoietic stem and progenitor cells (HSPCs). Consequently\, conventional CAR-T approaches frequently induce prolonged\, life-threatening myelosuppression and bone marrow aplasia severely limiting their clinical utility. This webinar by Dr. Marco Davila will explore a paradigm-shifting strategy developed at Roswell Park Comprehensive Cancer Center that addresses this exact barrier: a novel CAR-T design targeting the CD83 antigen. \nOur discussion will center on the unique biology of CD83\, a protein highly expressed on malignant AML blasts but distinctively regulated in healthy tissues\, offering a pathway to selectively suppress leukemia cells while sparing critical progenitor stem cells. Moving from bench to bedside\, we will detail the rigorous process development and GMP manufacturing frameworks involved in generating this CAR-T cell therapy to be tested in clinic. Finally\, we will share insights into the initiation and objectives of the first-of-its-kind\, active Phase 1 clinical trial evaluating autologous anti-CD83 CAR-T cell infusions in patients with relapsed or refractory AML. Join us to discover how this dual-action architecture reshapes safety\, efficacy\, and translation benchmarks in the myeloid cell therapy space. URL:https://thebiocalendar.com/event/car-t-for-relapsed-refractory-aml-from-discovery-to-first-in-human-active-phase-1-evaluation/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-20-26-Miltenyi-LinkedIn-1280x720-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260820T110000 DTEND;TZID=America/Los_Angeles:20260820T120000 DTSTAMP:20260812T144002Z CREATED:20260729T150317Z LAST-MODIFIED:20260812T144002Z UID:10888-1787223600-1787227200@thebiocalendar.com SUMMARY:Where Precision Drives Progress: Meeting the Rising Complexity of Modern Clinical Trials DESCRIPTION:Explore how leading teams are using trusted data and targeted AI to design\, plan\, and execute trials with the confidence today’s science requires. \nLearning outcomes:\n– Understand what’s driving trial complexity\n– Design protocols with confidence using real data + AI\n– Select sites based on holistic drivers of outcomes; access\, experience and past performance\n– Rethink patient recruitment as the critical success factor\n– Align with evolving regulatory expectations (ICH GCP E6 R3) URL:https://thebiocalendar.com/event/where-precision-drives-progress-meeting-the-rising-complexity-of-modern-clinical-trials/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-20-26-Citeline-eBlast-700x200-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260820T110000 DTEND;TZID=America/Los_Angeles:20260820T133000 DTSTAMP:20260806T155048Z CREATED:20260721T181456Z LAST-MODIFIED:20260806T155048Z UID:10823-1787223600-1787232600@thebiocalendar.com SUMMARY:BVS’ Biotech Community Event at The Alexandria at Torres Pines\, San Diego DESCRIPTION:Venue Update: Due to the hot weather\, the event has been moved to a new indoor location: Farmer & The Seahorse\, The Alexandria\, 10996 Torreyana Rd\, San Diego\, CA 92121 \nWe are very excited to announce our indoor Biotech Community Event at the Farmer & The Seahorse at The Alexandria at Torrey Pines. \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \n✨ What to Expect: \n Vendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\n Networking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\n Delicious Lunch & Drinks: Enjoy a delicious lunch as you network and explore the vendor exhibits. \nWe are inviting all the tenants and all local life science researchers and entrepreneurs in the surrounding area to attend. \nAdmission Details:\nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there! URL:https://thebiocalendar.com/event/bvs-biotech-community-event-at-one-alexandria-square-san-diego/ LOCATION:San Diego\, San Diego\, CA\, United States CATEGORIES:Trade Show ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/07/BVS-Biotech-Event-Flyer-08-20-26-2.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260821T110000 DTEND;TZID=America/Los_Angeles:20260821T120000 DTSTAMP:20260812T085415Z CREATED:20260728T181155Z LAST-MODIFIED:20260812T085415Z UID:10878-1787310000-1787313600@thebiocalendar.com SUMMARY:Container Closure Integrity Testing: Selecting a Test Method for your Container System DESCRIPTION:Join us for a practical discussion on selecting the right Container Closure Integrity Testing (CCIT) method for your container system. Learn how deterministic and probabilistic approaches compare\, understand the impact of package design and product characteristics on method selection\, and gain a risk-based framework for justifying your CCIT strategy to regulators. URL:https://thebiocalendar.com/event/container-closure-integrity-testing-selecting-a-test-method-for-your-container-system/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-21-26-Pace-eblast-700x200-1.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260824 DTEND;VALUE=DATE:20260827 DTSTAMP:20260511T225230Z CREATED:20260511T225230Z LAST-MODIFIED:20260511T225230Z UID:10419-1787529600-1787788799@thebiocalendar.com SUMMARY:Next Generation Dx Summit DESCRIPTION:Breakthrough Tech. Expert Insights. Real-World Impact. \n\n400+ diagnostics professionals from across the industry\n120+ speakers leading innovation in clinical and molecular Dx\n6 highly focused tracks spanning emerging technologies and commercial strategy\nUnmatched networking with partners\, labs\, regulators\, and investors\nEmerging company spotlight with novel platform technologies\n\nNext Generation Dx Summit is where the diagnostics ecosystem converges to accelerate innovation and expand patient access \n\n\n\n\nGain the latest insights in: \n\nClinical implementation and validation of diagnostic technologies\nPoint-of-care innovation and at-home testing\nEarly detection and enhanced screening of single cancers and MCEDs\nAI\, digital\, and emerging applications in companion diagnostics\nAI in lab management\, testing\, clinical decision support\, and analysis URL:https://thebiocalendar.com/event/next-generation-dx-summit-3/ LOCATION:Washington\, DC\, Washington\, DC\, United States CATEGORIES:Summit END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260825T090000 DTEND;TZID=America/Los_Angeles:20260825T110000 DTSTAMP:20260813T172159Z CREATED:20260812T182632Z LAST-MODIFIED:20260813T172159Z UID:11051-1787648400-1787655600@thebiocalendar.com SUMMARY:Biotech Breakfast: The Incubator + Vivarium Connection DESCRIPTION:Philly biotechs and emerging startups\, join Mispro and B+labs for breakfast and a behind-the-scenes look at the research spaces available at Cira Centre. \n​If you’re launching preclinical R&D in the next 6–12 months or currently outsourcing your program to a CRO\, this is an opportunity to learn how co-working incubator and contract vivarium space\, along with comprehensive support services\, can help your team move faster while maintaining the diligence today’s funding environment demands. \n​Mispro will share an inside look at its contract vivarium model\, including the dedicated space reserved for B+Labs companies and the services and support available as teams move into preclinical in vivo research. The morning will wrap with an open Q&A and optional tours of both B+Labs and Mispro. URL:https://thebiocalendar.com/event/biotech-breakfast-the-incubator-vivarium-connection/ LOCATION:Philadelphia\, Philadelphia\, PA\, United States CATEGORIES:Social END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260825T110000 DTEND;TZID=America/Los_Angeles:20260825T120000 DTSTAMP:20260812T085441Z CREATED:20260727T143248Z LAST-MODIFIED:20260812T085441Z UID:10870-1787655600-1787659200@thebiocalendar.com SUMMARY:Driving Measurable Productivity Gains in CHO Cell Culture DESCRIPTION:Achieving consistent upstream performance remains a critical challenge as bioprocesses become more complex and quality expectations continue to rise. From variability in raw materials to maintaining cell growth\, productivity\, and product quality across platforms\, process developers are under increasing pressure to build more robust and reliable manufacturing processes. \nJoin this webinar to explore practical strategies for optimizing upstream CHO cell culture performance through media component selection and process design. Through real-world application data and case studies spanning both monoclonal antibodies and emerging antibody modalities\, our experts will share insights into reducing variability\, improving process consistency\, and enhancing key cell culture outcomes. \nLearning Objectives:\n~ Understand the impact raw material variability can have on upstream process performance and product quality\n~ Explore approaches to improving consistency\, cell growth\, viability\, and productivity in CHO-based processes\n~ Review case studies demonstrating successful media optimization strategies across multiple antibody production workflows\n~ Gain practical insights to support media selection and upstream process development decisions URL:https://thebiocalendar.com/event/driving-measurable-productivity-gains-in-cho-cell-culture/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-25-26-Thermo-Reg-1920x250-rev.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260825T110000 DTEND;TZID=America/Los_Angeles:20260825T120000 DTSTAMP:20260812T085500Z CREATED:20260730T121133Z LAST-MODIFIED:20260812T085500Z UID:10897-1787655600-1787659200@thebiocalendar.com SUMMARY:Characterizing Process Performance and Robustness in an End-to-End Cryopreserved Autologous CAR-T/TCR Workflow DESCRIPTION:Explore data from an end-to-end CAR-T workflow using cryopreserved leukopaks. This session will examine how key process parameters affect cell recovery\, viability\, consistency\, and scalability across washing\, cryopreservation\, thawing\, and final formulation. \nAttendees will learn practical strategies for defining operating ranges\, reducing variability\, and building more robust closed-system autologous manufacturing workflows. URL:https://thebiocalendar.com/event/characterizing-process-performance-and-robustness-in-an-end-to-end-cryopreserved-autologous-car-t-tcr-workflow/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-25-26-CARR-eblast-700x200-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260825T110000 DTEND;TZID=America/Los_Angeles:20260825T120000 DTSTAMP:20260812T085518Z CREATED:20260731T151018Z LAST-MODIFIED:20260812T085518Z UID:10912-1787655600-1787659200@thebiocalendar.com SUMMARY:Optimizing Movement Disorder Clinical Trials: A Focus on Parkinson's Disease DESCRIPTION:Join experts from Dr. Vince Clinical Research\, along with moderator Polly Dawkins of the Davis Phinney Foundation\, for a practical discussion on designing and executing successful Parkinson’s disease clinical trials. The session will explore symptomatic and disease-modifying study designs\, endpoint selection\, emerging research trends and operational challenges. Attendees will gain real-world insights to help advance Parkinson’s disease programs from early development through NDA submission. URL:https://thebiocalendar.com/event/optimizing-movement-disorder-clinical-trials-a-focus-on-parkinsons-disease/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-25-26-DVCR-eBlast-700x200-1.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260826 DTEND;VALUE=DATE:20260828 DTSTAMP:20260727T152559Z CREATED:20260727T152559Z LAST-MODIFIED:20260727T152559Z UID:10875-1787702400-1787875199@thebiocalendar.com SUMMARY:MEDevice Boston DESCRIPTION:MEDevice Boston\, by Informa\, brings together leading medical device OEMs\, startups\, and suppliers from New England and beyond into a MedTech event engineered to advance the industry. \nIntentionally designed for partner connections and supplier evaluation\, this two-day experience creates a focused environment where high-intent buyers and solution providers connect. Through curated networking\, hands-on learning\, and dynamic on-site features\, MEDevice Boston drives meaningful conversations\, strategic partnerships\, and the technologies shaping the next generation of medical devices. URL:https://thebiocalendar.com/event/medevice-boston/ LOCATION:Boston\, MA\, 02210\, United States CATEGORIES:Summit END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260826T110000 DTEND;TZID=America/Los_Angeles:20260826T120000 DTSTAMP:20260725T054932Z CREATED:20260720T125405Z LAST-MODIFIED:20260725T054932Z UID:10801-1787742000-1787745600@thebiocalendar.com SUMMARY:Controlling UF/DF with Confidence: How to Define\, Monitor\, and Hit Critical Endpoints DESCRIPTION:A practical framework for reducing variability\, minimizing manual sampling\, and improving run-to-run consistency with modern UF/DF control strategies. \nAugust 26\, 2026 | 11:00 AM ET \nUltrafiltration Diafiltration (UF/DF) is often treated as a straightforward concentration and buffer-exchange step\, but teams know the reality looks different. Small differences in setup\, endpoint definition\, and in-process decision-making can create major run-to-run variability\, especially as programs move from process development into scale-up and manufacturing. \nIn this webinar\, we will focus on the practical question that determines whether UF/DF is repeatable and scalable: How do you define the right endpoints\, monitor them in real time\, and consistently hit them without relying on constant manual sampling and operator intervention? We will walk through a clear approach to selecting critical UF/DF endpoints (for concentration and diafiltration)\, connecting them to the right measurements\, and using in-line analytics to improve accuracy and consistency. \nKey topics include:\nWhat “critical endpoints” really mean in UF/DF\, and why unclear endpoints drive variability across runs and teams\nEndpoint selection made practical: choosing concentration and diafiltration endpoints that align with process goals and downstream requirements\nHow real-time\, in-line concentration data enables automated control\, reducing manual sampling and dilution while improving efficiency\, consistency\, and decision-making\nReducing variability across scales by linking endpoint definition\, monitoring strategy\, and execution consistency from PD through manufacturing\nTroubleshooting through the lens of control: how clearer endpoints and better monitoring help teams respond faster to instability and performance drift \nWhether you are building a UF/DF strategy in development\, preparing for tech transfer\, or tightening control in manufacturing\, this session will provide practical guidance for making UF/DF easier to run\, easier to scale\, and easier to reproduce. URL:https://thebiocalendar.com/event/controlling-uf-df-with-confidence-how-to-define-monitor-and-hit-critical-endpoints/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-26-26-Repligen-LinkedIn-1280x720-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260826T110000 DTEND;TZID=America/Los_Angeles:20260826T120000 DTSTAMP:20260730T185612Z CREATED:20260730T185612Z LAST-MODIFIED:20260730T185612Z UID:10908-1787742000-1787745600@thebiocalendar.com SUMMARY:How Leading Vivariums Are Solving Today’s Toughest Operational Challenges DESCRIPTION:Every vivarium faces similar pressures and challenges\, but not every team solves them the same way. \nIn this session\, we’ll highlight how organizations like yours are overcoming common challenges in staffing\, colony support\, workflow execution\, and compliance. \nThrough real-world examples\, you’ll gain insight into the decisions\, tradeoffs\, and strategies that helped these teams operate more efficiently and support their scientists more effectively. Leave with useful ideas\, fresh perspectives\, and practical next steps to consider for your own operations. \nYou’ll learn: \n\nHow organizations are maintaining operational continuity when staffing is stretched\nWays to improve animal care consistency and scientific outcomes\nProven approaches to streamline daily workflows and operational execution\nHow teams are scaling operations while maintaining quality and control\nWhat operational models and decisions are driving greater efficiency and reliability\n\nDesigned for: Vivarium directors\, facility managers\, operations leaders\, colony managers\, comparative medicine teams\, animal resources leaders\, in vivo research teams\, and HR professionals hiring to support these functions. URL:https://thebiocalendar.com/event/how-leading-vivariums-are-solving-todays-toughest-operational-challenges/ LOCATION:Online webinar CATEGORIES:Webinar END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260827T100000 DTEND;TZID=America/Los_Angeles:20260827T110000 DTSTAMP:20260812T085548Z CREATED:20260728T181700Z LAST-MODIFIED:20260812T085548Z UID:10883-1787824800-1787828400@thebiocalendar.com SUMMARY:Outsourced Pharma Capabilities Update: CPHI Milan 2026 Special Edition DESCRIPTION:Are you making the most of your time at CPHI Milan? \nWatch this free virtual event to evaluate CDMOs\, CMOs\, API suppliers\, packaging providers\, and other outsourcing partners before you arrive onsite. Gain early insight into supplier capabilities\, compare potential partners\, and build a focused meeting strategy that maximizes your time at CPHI Milan. \nRegister today to identify the right partners\, prioritize high-value conversations\, and arrive in Milan ready to make informed outsourcing decisions. URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-cphi-milan-2026-special-edition/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/Biocal-27.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260831 DTEND;VALUE=DATE:20260901 DTSTAMP:20260504T221917Z CREATED:20260504T221917Z LAST-MODIFIED:20260504T221917Z UID:10339-1788134400-1788220799@thebiocalendar.com SUMMARY:ESC Congress 2026 DESCRIPTION:Join us and experience transformation through practice\, policy\, responsibility and genuine human connection. \nThis year’s Spotlight on Artificial Intelligence explores how AI is becoming a co-pilot\, enhancing precision\, speed\, and safety in patient care. Discover AI in action\, from diagnosis to delivery\, through hands-on sessions\, live demonstrations\, and immersive learning. \nHere we will explore a diverse range of topics\, uniting all subspecialties to create a space to share breakthrough data and debate new ideas\, before applying innovation to real-world settings. \nThis is where collaboration becomes progress\, and transformation is not just seen\, but felt. URL:https://thebiocalendar.com/event/esc-congress-2026/ LOCATION:Munich\, Munich\, Bavaria\, Germany CATEGORIES:Seminar,Summit END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260901 DTEND;VALUE=DATE:20260903 DTSTAMP:20260709T104118Z CREATED:20260709T104118Z LAST-MODIFIED:20260709T104118Z UID:10750-1788220800-1788393599@thebiocalendar.com SUMMARY:Hubs West DESCRIPTION:The Hub and Specialty Pharmacy Model conference series returns to sunny San Diego\, CA at the stunning Estancia La Jolla Hotel & Spa. Demand for agile\, scalable and innovative programs are at an all time high as market dynamics continue to evolve and regulatory changes remains unclear. This event brings together top industry experts to equip you with cutting-edge technologies and actionable insights to enhance patient outcomes. Hub and Specialty Pharmacy Models West is the premier event for professionals seeking unparalleled networking opportunities and expert-driven content to refine their hub strategies and elevate their patient services suite. URL:https://thebiocalendar.com/event/hubs-west/ LOCATION:San Diego\, San Diego\, CA\, United States CATEGORIES:Networking,Summit END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260902T110000 DTEND;TZID=America/Los_Angeles:20260902T120000 DTSTAMP:20260812T085616Z CREATED:20260805T154159Z LAST-MODIFIED:20260812T085616Z UID:10924-1788346800-1788350400@thebiocalendar.com SUMMARY:AI-Readiness in a Regulated World: A Practical Playbook for Life Sciences DESCRIPTION:In this practical session\, Jake Walton\, VP of Quality & Compliance at MasterControl\, will share a candid look at how MasterControl approached AI the right way from the start—building human-in-the-loop architecture as a non-negotiable design principle\, aligning every capability to 21 CFR Part 11\, EU MDR\, GDPR\, HIPAA\, and other applicable standards\, and going all the way through ISO 42001 certification for Artificial Intelligence Management Systems. URL:https://thebiocalendar.com/event/ai-readiness-in-a-regulated-world-a-practical-playbook-for-life-sciences/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-02-26-MasterControl-LinkedIn-1280x720-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260902T110000 DTEND;TZID=America/Los_Angeles:20260902T120000 DTSTAMP:20260812T085636Z CREATED:20260805T160301Z LAST-MODIFIED:20260812T085636Z UID:10929-1788346800-1788350400@thebiocalendar.com SUMMARY:A CCS is a purpose-built machine\, not a black box: Understand the workings DESCRIPTION:A contamination control strategy (CCS) is usually treated as a document with sixteen elements assembled\, signed\, and shelved. This webinar offers a new perspective of a CCS as a machine that is not so complex that it cannot be analyzed component by component. URL:https://thebiocalendar.com/event/a-ccs-is-a-purpose-built-machine-not-a-black-box-understand-the-workings-2/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-02-25-CAI-LinkedIn-1280x720-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260902T110000 DTEND;TZID=America/Los_Angeles:20260902T120000 DTSTAMP:20260812T085657Z CREATED:20260805T181245Z LAST-MODIFIED:20260812T085657Z UID:10936-1788346800-1788350400@thebiocalendar.com SUMMARY:Enabling the full potential of process chromatography DESCRIPTION:Successfully scaling a purification process from development to GMP manufacturing requires maintaining process performance while minimizing variability. However\, scale-up often introduces challenges that can impact productivity\, recovery\, and overall process efficiency. To mitigate risk\, manufacturers frequently apply conservative safety factors during scale-up—resulting in lower resin utilization\, increased buffer consumption\, longer process times\, and reduced overall productivity. \nWhat if you could maintain the same critical process parameters (CPPs) and critical quality attributes (CQAs) from bench scale through commercial manufacturing with greater confidence and control? \nJoin Repligen for an in-depth discussion on how advanced process control and real-time analytics can help close the gap between process development and manufacturing performance. \nThis webinar will explore key considerations for implementing real-time monitoring and control strategies in chromatography processes. Industry experts will discuss the capabilities of the KRM® chromatography platform and the integration of FlowVPX® Process Analytical Technology (PAT) for in-line product concentration measurement. \nAttendees will learn how these technologies can be applied to support process characterization\, monitor purification performance\, and generate data that may inform scale-up and manufacturing decisions while maintaining focus on critical quality attributes. \nWhat You’ll Learn: \nWhy purification processes often lose efficiency during scale-up\nHow improved process accuracy and precision can increase yield and productivity\nBest practices for maintaining CPPs and CQAs from development through GMP manufacturing\nHow the KRM® platform supports advanced chromatography process control\nHow integrated FlowVPX® PAT enables real-time concentration monitoring and process optimization\nStrategies to improve resin utilization\, reduce buffer consumption\, and maximize recovery \nWho Should Attend? \nProcess Development Scientists\nDownstream Process Engineers\nManufacturing Scientists\nMSAT Professionals\nBiologics and Cell & Gene Therapy Professionals\nPurification and Chromatography Specialists \nRegister Today \nDiscover how real-time process analytics and intelligent chromatography control can help you achieve higher yields\, greater process consistency\, improved resin utilization\, and increased manufacturing productivity—without compromising product quality. URL:https://thebiocalendar.com/event/enabling-the-full-potential-of-process-chromatography/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-02-26-Repligen-Reg-1920x250-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260908T160000 DTEND;TZID=America/Los_Angeles:20260908T170000 DTSTAMP:20260812T085719Z CREATED:20260805T181903Z LAST-MODIFIED:20260812T085719Z UID:10946-1788883200-1788886800@thebiocalendar.com SUMMARY:Beyond breakdowns: Building a culture of proactive maintenance DESCRIPTION:Across biopharma operations\, reactive “run‑to‑failure” maintenance is one of the biggest hidden drivers of downtime\, deviations\, and escalating lifecycle cost. As the industry moves toward digital maturity\, organizations are shifting from calendar‑based activities to proactive\, engineering‑driven practices that eliminate root causes\, strengthen compliance\, and create the foundation for future predictive and prescriptive strategies. \nProactive maintenance focuses on precision\, consistency\, and early intervention—addressing the mechanical\, procedural\, and environmental factors that lead to recurring failures. This approach not only reduces unplanned downtime and costly emergency service but also supports audit readiness through clear documentation and alignment with Original Equipment Manufacturer (OEM) best practices. For most sites\, these fundamentals deliver the fastest\, highest‑ROI reliability gains long before advanced analytics or AI‑driven tools come into play. \nJoin our session to explore how proactive maintenance can significantly improve equipment uptime\, operational resilience\, and regulatory confidence while preparing your organization for the next stages of digital reliability. \nIn this session\, you will: \nUnderstand the maintenance maturity pyramid and how to intentionally progress through each level\nLearn how proactive\, hands‑on maintenance practices reduce failures and improve cost efficiency\nExplore how lifecycle management integrates with preventive\, proactive\, and predictive strategies\nGain practical tips for implementing proactive maintenance today—and preparing for a predictive or prescriptive culture in the future URL:https://thebiocalendar.com/event/beyond-breakdowns-building-a-culture-of-proactive-maintenance/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-08-26-Cytiva-LinkedIn-1280x720-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20260909T110000 DTEND;TZID=America/New_York:20260909T120000 DTSTAMP:20260812T085742Z CREATED:20260810T191003Z LAST-MODIFIED:20260812T085742Z UID:11005-1788951600-1788955200@thebiocalendar.com SUMMARY:How to Achieve Stable\, High-Output Stickpack Production DESCRIPTION:The key to unlocking maximum OEE? Integrating dosing accuracy\, platen sealing\, magnetic shuttle transport\, and automated 100% in-line quality control into a unified workflow. \nJoin our virtual event\, “How to Achieve Stable\, High-Output Stickpack Production” with packaging expert René Schubert (Körber Pharma). \nWhy you can’t afford to miss this:\n– Discover how integrated stickpack & cartoning lines simplify operations.\n– Learn technology levers (platen sealing\, magnetic shuttle transport) that slash waste and boost uptime.\n– Future-proof your facility for regulatory compliance and sustainability goals. URL:https://thebiocalendar.com/event/how-to-achieve-stable-high-output-stickpack-production/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-09-26-Koerber-eBlast-700x200-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260910T110000 DTEND;TZID=America/Los_Angeles:20260910T120000 DTSTAMP:20260812T085808Z CREATED:20260805T181605Z LAST-MODIFIED:20260812T085808Z UID:10941-1789038000-1789041600@thebiocalendar.com SUMMARY:Scaling Next-Gen MSC Therapies Without Scaling Risk DESCRIPTION:Mesenchymal stromal cell (MSC) therapies are entering a pivotal stage of development. As more programs move toward late-stage clinical trials and commercialization\, developers must produce enough high-quality cells to meet growing demand while maintaining potency\, consistency\, and manufacturability. How can companies scale MSC production without compromising the biological properties that drive therapeutic efficacy? \nJoin Cell & Gene’s Chief Editor\, Erin Harris\, for this Cell & Gene Live discussion featuring Miguel Forte\, M.D.\, Ph.D.\, CEO of Kiji Therapeutics\, Silviu Itescu\, M.D.\, Founder\, CEO\, and Managing Director of Mesoblast\, and Edward Ahn\, Ph.D.\, CEO of MEDIPOST. Together\, these experts bring decades of experience developing\, manufacturing\, and commercializing MSC therapies. Their combined expertise spans early innovation\, scalable manufacturing\, and commercial execution. \nThe expert panel will discuss strategies for scaling MSC therapies while minimizing donor variability\, preserving potency\, improving process consistency\, and building commercially viable manufacturing platforms. They will also examine advances in cell sourcing\, process development\, quality systems\, and manufacturing strategy. Attendees will leave with practical insights into what developers should prioritize today to improve their products’ chances of clinical and commercial success. \nRegistration is free. URL:https://thebiocalendar.com/event/scaling-next-gen-msc-therapies-without-scaling-risk/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/26_09_CGL-LinkedIn-1280x720-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260910T110000 DTEND;TZID=America/Los_Angeles:20260910T120000 DTSTAMP:20260813T125211Z CREATED:20260813T125211Z LAST-MODIFIED:20260813T125211Z UID:11060-1789038000-1789041600@thebiocalendar.com SUMMARY:Autonomous Impinging Jet Mixing for LNP Process Development DESCRIPTION:Lipid nanoparticles (LNPs) are critical to the delivery of genetic medicines\, but developing scalable\, reproducible manufacturing processes remains complex and resource-intensive. Because LNP quality can be highly sensitive to formulation and processing conditions\, identifying the right parameters efficiently is essential. \nThis webinar will explore how impinging jet mixing\, automation\, inline analytics\, and data-driven optimization can accelerate LNP process development. Attendees will see how automated design of experiments\, dynamic process sweeps\, self-optimization\, and predictive modeling can help map process-property relationships and identify conditions that achieve target quality attributes. URL:https://thebiocalendar.com/event/autonomous-impinging-jet-mixing-for-lnp-process-development/ ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-10-26-Knauer-eBlast-700x200-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20260910T110000 DTEND;TZID=America/New_York:20260910T130000 DTSTAMP:20260812T085824Z CREATED:20260811T193706Z LAST-MODIFIED:20260812T085824Z UID:11017-1789038000-1789045200@thebiocalendar.com SUMMARY:BVS’ Longwood Galleria Tech Vendor Expo at the Inn at Longwood\, Boston DESCRIPTION:We are very excited to announce that this premier Expo will occur at The Inn at Longwood\, Longwood Hall centrally located in the food court at the hotel. \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nThis event will attract researchers from the many institutions situated in the Longwood medical area that include the following: Harvard Medical School\, Harvard School of Public Health\, Dana Farber Cancer Institute\, Boston Children’s Hospital\, Brigham & Women’s Hospital and Beth Israel Deaconess Hospital. \n✨ What to Expect: \nVendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\nNetworking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\nDelicious Food & Drinks: Enjoy delicious refreshments as you network and explore the vendor exhibits. \nAdmission Details:\nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there! URL:https://thebiocalendar.com/event/bvs-longwood-galleria-tech-vendor-expo-at-the-inn-at-longwood-3/ LOCATION:Boston\, MA\, 02210\, United States CATEGORIES:Expo,Trade Show ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/08/BVS-Biotech-Event-Flyer-09-10-26.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260911T110000 DTEND;TZID=America/Los_Angeles:20260911T120000 DTSTAMP:20260812T085847Z CREATED:20260805T182248Z LAST-MODIFIED:20260812T085847Z UID:10951-1789124400-1789128000@thebiocalendar.com SUMMARY:De-Risking Cell Culture Media Scale-Up for Late-Stage Manufacturing DESCRIPTION:Strategies for supply assurance\, QC readiness\, digital optimization\, and commercial bioprocessing success. \nThe translation of cell culture processes from laboratory-scale development to commercial manufacturing remains one of the most critical challenges in bioprocessing. While small-scale systems provide valuable insights into cell growth\, productivity\, and product quality\, scale-up introduces complex engineering and biological variables that can significantly impact process performance. Scale-up also comes with additional considerations that can greatly impact efficiency\, cost and speed-to-market. \nIn this webinar\, a panel of experienced professionals from Thermo Fisher Scientific will explore potential challenges encountered during cell culture media manufacturing scale-up\, options and solutions. A sample of topics will include: \nSupply assurance—approaches to help ensure transparent and uninterrupted global supply of your cell culture media\nBenefits of granular cell culture media formats\, including preparation time productivity and financial savings models\nManaging emerging QC considerations to meet new regulatory requirements\nHow digital tools are helping change how media formulations are designed and optimized\nCase study real-world examples of how Thermo Fisher has worked with customers to successfully navigate late-stage media manufacturing \nThis session includes a Q and A with our presenters immediately following the presentation. URL:https://thebiocalendar.com/event/de-risking-cell-culture-media-scale-up-for-late-stage-manufacturing/ LOCATION:Online webinar CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/08/09-11-26-Thermo-Reg-1920x250-0.png END:VEVENT END:VCALENDAR